Enter at least 3 characters

Autorizzo al trattamento dei miei dati personali
ai sensi del D.L. 30 giugno 2003 n. 196
Edit email address
Invalid email
Your request has been sent successfully
Authorize the processing of personal data

In respiratory diseases, our indications of interest are: COPD, Asthma, Chronic Cough, Cystic Fibrosis, Idiopathic Pulmonary Fibrosis, non-CF bronchiectasis, Pulmonary Arterial Hypertension, and Acute Respiratory Distress Syndrome. Within neonatology, we are interested in therapeutic opportunities addressing areas of unmet medical need, including, but not limited to: Bronchopulmonary Dysplasia, Neonatal Brain Injury, Retinopathy of Prematurity, and Neonatal Respiratory Distress Syndrome. Ideally, the target would be well defined, the mechanism of action understood, with therapeutically-relevant preclinical data.

 

We look forward to hearing from researchers and physician-scientists working in these areas of interest who are keen to collaborate with a global pharma company with a strong track record of translational R&D in respiratory and neonatology care.